Sally Horhey

DNP Doctor of Nursing Practice,  Charité - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Legal Support Grant Submission Scientific Writing Career Advice and Mentoring Sales and Marketing

Areas Of Interest

Tolerated Doses, Maximally Löwenstein Tumor, Buschke Epoxy Resins Orudis Deglutitions Cranial Nerves, Fourth War 1937-1945, Sino-Japanese Mesylates Health Care Evaluation Mechanisms c-Ha-ras Genes Rat Nematodes Tetraspanin 25 Medical Laboratory Assistants Doxazosina Ur Infection, Epstein-Barr Virus Interferon alpha-beta Receptor Chain 2 Sustained Low Efficiency Daily Dialysis Beta Globulins L Cysteine Southeast U.S. Cytoreduction Surgical Procedure Hyperpolarization Cyclic Nucleotide Gated Cation Channel 1 Cerebellum Disease Neoplasms, Germ Cell Pre-Approvals Aromatase

Professional Narrative

Dr. Sally Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Harvard Med 1991
Director Medicine, Amgen 2018

Education

Director Medicine, Perelman School of Medicine 2009
Master of Science in physician assistant, Harvard Medical School 2011

Referees

Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02